GENTILUOMO, MANUEL
 Distribuzione geografica
Continente #
NA - Nord America 3.090
AS - Asia 2.244
EU - Europa 1.416
SA - Sud America 392
AF - Africa 153
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.304
Nazione #
US - Stati Uniti d'America 3.000
SG - Singapore 697
IT - Italia 625
CN - Cina 545
HK - Hong Kong 368
BR - Brasile 317
VN - Vietnam 242
SE - Svezia 153
DE - Germania 150
FR - Francia 102
IN - India 79
GB - Regno Unito 76
JP - Giappone 72
KR - Corea 62
BG - Bulgaria 59
FI - Finlandia 53
CI - Costa d'Avorio 52
AT - Austria 45
RU - Federazione Russa 45
CA - Canada 40
BD - Bangladesh 30
TR - Turchia 30
AR - Argentina 29
MA - Marocco 25
SN - Senegal 25
IQ - Iraq 24
MX - Messico 24
NL - Olanda 23
CZ - Repubblica Ceca 13
PK - Pakistan 13
ZA - Sudafrica 13
CH - Svizzera 12
EC - Ecuador 12
UZ - Uzbekistan 12
ID - Indonesia 11
PL - Polonia 11
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
EE - Estonia 8
IE - Irlanda 8
MY - Malesia 8
TN - Tunisia 8
DZ - Algeria 7
EG - Egitto 7
PA - Panama 7
AU - Australia 6
AZ - Azerbaigian 6
ES - Italia 6
CR - Costa Rica 5
JM - Giamaica 5
JO - Giordania 5
NG - Nigeria 5
PY - Paraguay 5
BE - Belgio 4
CL - Cile 4
IL - Israele 4
PH - Filippine 4
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MR - Mauritania 1
NA - Namibia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
Totale 7.297
Città #
Singapore 409
Ashburn 404
Dallas 400
Hong Kong 357
San Jose 244
Santa Clara 236
Chandler 122
Shanghai 114
Fairfield 112
Los Angeles 101
New York 88
Hefei 86
Milan 81
Woodbridge 80
Boardman 76
Houston 73
Pisa 73
Serra 67
Beijing 66
Ho Chi Minh City 66
Council Bluffs 59
Tokyo 59
Hanoi 58
Sofia 58
Seoul 57
Abidjan 52
Florence 51
Munich 49
Wilmington 48
Frankfurt am Main 45
Rome 42
Lauterbourg 39
Princeton 39
Vienna 37
Lawrence 35
Seattle 35
London 29
Cambridge 28
Lucca 28
Helsinki 26
Buffalo 25
Dakar 25
Nuremberg 25
Redondo Beach 24
Medford 23
São Paulo 21
Ann Arbor 20
Pune 18
Casablanca 17
Genoa 16
Hyderabad 16
Rio de Janeiro 16
Turku 16
Columbus 15
Ogden 15
Amsterdam 14
Chicago 14
Istanbul 13
Baghdad 12
Da Nang 12
Ottawa 12
San Diego 12
Piombino 11
Salt Lake City 11
Tashkent 11
The Dalles 11
Zurich 11
Bremen 10
Des Moines 10
Dong Ket 10
Guarulhos 10
Orem 10
Toronto 10
Boulder 9
Düsseldorf 9
Kent 9
Warsaw 9
Atlanta 8
Calci 8
Dubai 8
Dublin 8
Fuzhou 8
Mexico City 8
Quanzhou 8
Stockholm 8
Biên Hòa 7
Brasília 7
Brno 7
Brooklyn 7
Capannori 7
Dhaka 7
Haiphong 7
Johannesburg 7
Lappeenranta 7
Livorno 7
Marseille 7
Padova 7
Paris 7
Baku 6
Chennai 6
Totale 4.828
Nome #
In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration 192
Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma 186
RNA-SCOPE TECHNOLOGY AND IMMUNOHISTOCHEMISTRY REVEAL LOW EXPRESSION OF MUC5AC IN METASTATIC PANCREATIC PATIENTS: EPIGENETIC PITFALLS OR A BETTER DISEASE STATUS? 176
Epigenetic expression of MUC5AC in metastatic pancreatic patients using RNA-scope technology and immunohistochemistry 176
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 175
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians 166
Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 165
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 164
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 161
Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort 159
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk 158
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 156
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 156
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 155
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 150
A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma 148
Genetic and non-genetic risk factors for early-onset pancreatic cancer 145
Germline genetic variability in pancreatic cancer risk and prognosis 145
Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study 144
Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma 143
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 141
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 140
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer 140
Role of OPRM1, clinical and anthropometric variants in neonatal pain reduction 136
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 133
Genetically determined telomere length is associated with pancreatic neuroendocrine neoplasms onset 129
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women 126
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 126
Genetic variants in taste-related genes and risk of pancreatic cancer 123
Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer 123
Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients 121
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 119
Taste receptor polymorphisms and male infertility 118
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 118
Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization 116
TUMOR VOLUME AND MICROSATELLITE INSTABILITY INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 115
THE ROLE OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY IN ADJUVANT SETTING OF PANCREATIC DUCTAL ADENOCARCINOMA: TUMOR VOLUME AND MICROSATELLITE INSTABILITY INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL 113
null 112
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 112
Telomere length and male fertility 111
TAS2R38 polymorphisms, Helicobacter pylori infection and susceptibility to gastric cancer and premalignant gastric lesions 110
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome 109
Polymorphic variants in Sweet and Umami taste receptor genes and birthweight 107
Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals 106
Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review 105
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 99
Association between telomere length and mitochondrial copy number and cancer risk in humans: A meta-analysis on more than 300,000 individuals 95
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 94
Physical Activity, Sedentary Behavior, and Pancreatic Cancer Risk: A Mendelian Randomization Study 91
Mitochondrial DNA abundance in blood is associated with Alzheimer's disease- and dementia-risk 90
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 87
Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors 84
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival 83
Genome-wide association study identifies an early onset pancreatic cancer risk locus 80
Genome-wide association study of mitochondrial copy number 72
null 65
Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: A pathway analysis of genome-wide association studies 52
Polymorphic variants involved in methylation regulation: a new strategy to discover risk loci for pancreatic ductal adenocarcinoma 40
Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer 39
Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis 38
From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction 35
Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer 34
Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk 33
Genetic landscape for screening and early diagnosis of pancreatic ductal adenocarcinoma: is there a signature? 31
Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer 28
Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort 23
null 5
Totale 7.527
Categoria #
all - tutte 23.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022318 13 10 5 6 52 33 21 9 36 29 28 76
2022/2023583 62 83 43 23 58 60 8 42 126 5 64 9
2023/2024588 39 46 72 29 81 92 30 10 12 9 95 73
2024/20252.080 12 54 74 94 141 235 185 118 183 277 284 423
2025/20263.274 243 348 437 304 259 212 564 179 242 253 109 124
2026/202718 18 0 0 0 0 0 0 0 0 0 0 0
Totale 7.527